title: Commentary on an article by Rick Delamarter, MD, et al.: "Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level degenerative lumbar disc disease. Results at twenty-four months".
authors.affiliation: Department of Orthopaedic Surgery, William Beaumont Army Medical Center, El Paso, TX, USA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Schoenfeld
mesh_terms: D019643:Arthroplasty, Replacement / Q000295:instrumentation*; D018795:Device Approval; D004185:Disability Evaluation; D006801:Humans; D007403:Intervertebral Disc; D055959:Intervertebral Disc Degeneration / Q000150:complications / Q000601:surgery*; D017116:Low Back Pain / Q000209:etiology / Q000601:surgery*; D008159:Lumbar Vertebrae / Q000601:surgery*; D015337:Multicenter Studies as Topic; D017060:Patient Satisfaction; D011183:Postoperative Complications; D019736:Prostheses and Implants; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D016059:Range of Motion, Articular; D020127:Recovery of Function; D013123:Spinal Fusion / Q000295:instrumentation; D014481:United States; D014486:United States Food and Drug Administration